Tirzetta Drug Based on Tirzepatide Launched in Kazakhstan

The Russian company 'Promomed' has launched the drug 'Tirzetta' (INN - tirzepatide) in Kazakhstan. The launch occurred at a forum discussing metabolic health, attended by endocrinologists from Kazakhstan and Russia. The drug is registered in Kazakhstan, highlighting the healthcare system's recognition of this drug class's importance.

Read the full article at LS →

Headline and summary written by daryo. The full report belongs to LS.